Detalles de la búsqueda
1.
Development and Validation of SCACOMS, a Composite Scale for Assessing Disease Progression and Treatment Effects in Spinocerebellar Ataxia.
Cerebellum
; 2024 May 07.
Artículo
Inglés
| MEDLINE | ID: mdl-38710966
2.
Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet
; 399(10329): 1049-1058, 2022 03 12.
Artículo
Inglés
| MEDLINE | ID: mdl-35279258
3.
Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis.
N Engl J Med
; 383(10): 919-930, 2020 09 03.
Artículo
Inglés
| MEDLINE | ID: mdl-32877582
4.
Why a clinical trial is as good as its outcome measure: A framework for the selection and use of cognitive outcome measures for clinical trials of Alzheimer's disease.
Alzheimers Dement
; 19(2): 708-720, 2023 02.
Artículo
Inglés
| MEDLINE | ID: mdl-36086926
5.
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial.
J Neurol Neurosurg Psychiatry
; 2022 May 16.
Artículo
Inglés
| MEDLINE | ID: mdl-35577511
6.
Survival analyses from the CENTAUR trial in amyotrophic lateral sclerosis: Evaluating the impact of treatment crossover on outcomes.
Muscle Nerve
; 66(2): 136-141, 2022 08.
Artículo
Inglés
| MEDLINE | ID: mdl-35508892
7.
Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis.
Muscle Nerve
; 63(1): 31-39, 2021 01.
Artículo
Inglés
| MEDLINE | ID: mdl-33063909
8.
36-month LipiDiDiet multinutrient clinical trial in prodromal Alzheimer's disease.
Alzheimers Dement
; 17(1): 29-40, 2021 01.
Artículo
Inglés
| MEDLINE | ID: mdl-32920957
9.
A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study.
Alzheimers Dement
; 16(10): 1412-1425, 2020 10.
Artículo
Inglés
| MEDLINE | ID: mdl-32715623
10.
Individualized clinical management of patients at risk for Alzheimer's dementia.
Alzheimers Dement
; 15(12): 1588-1602, 2019 12.
Artículo
Inglés
| MEDLINE | ID: mdl-31677936
11.
Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial.
PLoS Med
; 15(9): e1002660, 2018 09.
Artículo
Inglés
| MEDLINE | ID: mdl-30248105
12.
Memantine ER Maintains Patient Response in Moderate to Severe Alzheimer's Disease: Post Hoc Analyses From a Randomized, Controlled, Clinical Trial of Patients Treated With Cholinesterase Inhibitors.
Alzheimer Dis Assoc Disord
; 32(3): 173-178, 2018.
Artículo
Inglés
| MEDLINE | ID: mdl-29771687
13.
The clinical practice of risk reduction for Alzheimer's disease: A precision medicine approach.
Alzheimers Dement
; 14(12): 1663-1673, 2018 12.
Artículo
Inglés
| MEDLINE | ID: mdl-30446421
14.
Statistical properties of continuous composite scales and implications for drug development.
J Biopharm Stat
; 27(6): 1104-1114, 2017.
Artículo
Inglés
| MEDLINE | ID: mdl-28402165
15.
ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials.
J Neurol Neurosurg Psychiatry
; 87(9): 993-9, 2016 09.
Artículo
Inglés
| MEDLINE | ID: mdl-27010616
16.
An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease.
Alzheimers Dement
; 10(6): 666-74, 2014 Nov.
Artículo
Inglés
| MEDLINE | ID: mdl-24751827
17.
Safety, tolerability, and efficacy estimate of evoked gamma oscillation in mild to moderate Alzheimer's disease.
Front Neurol
; 15: 1343588, 2024.
Artículo
Inglés
| MEDLINE | ID: mdl-38515445
18.
Hierarchical Bayesian cognitive processing models to analyze clinical trial data.
Alzheimers Dement
; 9(4): 422-8, 2013 Jul.
Artículo
Inglés
| MEDLINE | ID: mdl-23123230
19.
Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force.
Alzheimers Dement
; 9(4): 438-44, 2013 Jul.
Artículo
Inglés
| MEDLINE | ID: mdl-23809364
20.
Meaningful Clinical Changes in Alzheimer Disease Measured With the iADRS and Illustrated Using the Donanemab TRAILBLAZER-ALZ Study Findings.
Neurol Clin Pract
; 13(2): e200127, 2023 Apr.
Artículo
Inglés
| MEDLINE | ID: mdl-36891463